Skip to content
Cosmetic / Skin Widely used as a cosmetic skincare ingredient in topical formulations; not an approved medicine for systemic or injected use in Australia. Much of the supporting evidence is laboratory-based.

GHK-Cu

Also known as: Copper tripeptide-1, Copper Peptide GHK-Cu

GHK-Cu is a naturally occurring copper-binding tripeptide widely used as a cosmetic skincare ingredient. It is reported to support skin appearance in topical products, but it is not an approved medicine for systemic or injected use in Australia.

Category
Cosmetic / Skin
Reported half-life
Not well established
Common forms
Topical cosmetic serums and creams, Lyophilised powder (cosmetic raw material)
Research status
Widely used as a cosmetic skincare ingredient in topical formulations; not an approved medicine for systemic or injected use in Australia. Much of the supporting evidence is laboratory-based.
Last updated
21 June 2026

Claimed effects

The following effects are reported or claimed by users and in early research. They are not established medical facts and many are not supported by large human trials.

  • Reported to support the appearance of skin firmness and elasticity in topical use
  • Reported to be associated with collagen and extracellular matrix activity in laboratory studies
  • Reported to have antioxidant-related properties in research settings
  • Reported to be studied for wound-healing-related processes in laboratory models

How it is reported to work

GHK-Cu is proposed to act as a copper-delivery tripeptide that binds and shuttles copper ions, which some laboratory studies associate with signalling related to collagen and extracellular matrix remodelling. These proposed mechanisms come largely from in vitro and animal research and should be regarded as preliminary rather than established.

Background

GHK-Cu is a small copper-binding tripeptide (glycyl-L-histidyl-L-lysine bound to copper) that occurs naturally in the body and is commonly added to cosmetic skincare products. This page is educational information, not medical advice, and the effects described below are reported claims, not established facts.

What the research shows

Much of the published research on GHK-Cu consists of laboratory and animal studies, alongside smaller cosmetic-formulation evaluations. These suggest possible roles related to skin appearance and matrix activity, but they do not establish medical benefit.

Evidence typeStatus
Laboratory (in vitro) studiesPresent
Animal studiesPresent
Cosmetic formulation studiesSome
Large clinical trialsLimited
Australian medicine approvalNone

What people use it for (reported)

In cosmetics, GHK-Cu is reported to be included in serums and creams aimed at the look of skin firmness and texture. These are reported, often cosmetic-marketing claims, not validated clinical outcomes, and nothing here should be read as encouragement to use it in any particular way.

Things to be aware of

GHK-Cu is used as a topical cosmetic ingredient and is not an approved medicine for injected or systemic use in Australia. The safety of non-topical use is not well understood, and grey-market preparations cannot be verified for purity or identity by sight. If you have a skin or health concern, the appropriate step is to speak with a qualified healthcare professional. This article does not recommend obtaining or using GHK-Cu outside of approved cosmetic products. Remember that all effects described here are reported claims, not established facts.

Reported positives & side effects

Compiled from research and community reports. These are reported outcomes, not guarantees or medical advice, individual experiences vary widely.

Reported positives

  • Reported in topical use to support the appearance of skin firmness and elasticity
  • Reported to be associated with smoother skin texture and reduced fine lines
  • Reported to be linked with improved skin tone and reduced appearance of photo-damage
  • Reported antioxidant-related properties in research settings
  • Reported to be associated with skin-repair and wound-healing processes in laboratory models

Common side effects

  • Reported mild redness or irritation at the application site
  • Reported temporary stinging or tingling on application
  • Reported dryness or flaking with frequent use
  • Reported transient blue-green staining from the copper content

Rare / serious side effects

  • Reported contact allergy or sensitisation to copper peptides
  • Reported worsening irritation when combined with strong actives such as high-strength acids or retinoids
  • Reported reactions to contaminated or mislabelled unregulated raw material

Reported misuse & overdose risks

What has been reported to happen with overuse, excessive dosing, or long-term misuse of GHK-Cu. Listed so you can make an informed decision, not to suggest any use is safe.

  • Reported over-application or layering with too many actives, leading to irritation and a compromised skin barrier
  • Reported attempts to inject or use cosmetic-grade GHK-Cu systemically, which is not an approved or characterised use
  • Reported use of unregulated raw powder of unverified purity for DIY formulations
  • Reported combining with strong exfoliants in the same routine, increasing irritation

Reported results timeline

Roughly how long people report it takes to notice effects. A general guide from reports, not a promise, and not advice. Users typically report gradual skin appearance changes over 4-12 weeks of regular topical application.

  1. First effects

    Some report improved skin hydration and smoothness in the first weeks

  2. Noticeable change

    Reported improvement in texture and fine lines with regular application

  3. Clear results

    Reported firmness and tone changes described over a few months of consistent use

Commonly reported dosing & protocol

Reported figures only, NOT a recommendation or dosing advice. These are numbers people report using, compiled for education so you can make an informed decision. We do not advise anyone to take GHK-Cu. Many peptides are not approved for human use in Australia. Speak to a qualified healthcare professional.

Commonly reported dosing for GHK-Cu
RouteTopical serum/cream
Typical reported doseReported at roughly 1–2% in a serum
FrequencyReported 1–2× daily applied to skin
Cycle lengthReported as ongoing, with results over weeks of regular use

Reported topical use is commonly described as applying a serum once or twice daily as part of a skincare routine, with reported results over 4-12 weeks of consistent application. This is reported information, not advice.

Best used with / commonly stacked with

Combinations people report using together. Reported, not recommended, stacking can increase risks.

Matrixyl

Reported layered in skincare routines for complementary collagen-appearance claims

Argireline

Reported combined in topical routines targeting fine lines and firmness

SNAP-8

Reported alongside other cosmetic peptides in expression-line-focused routines

Safety notes

GHK-Cu is used in topical cosmetics but is not an approved medicine for injected or systemic use in Australia. The safety of non-topical use is not well characterised and grey-market product purity cannot be verified by consumers. Anyone with a skin or health concern should consult a qualified healthcare professional.

References

  1. PubMed, GHK-Cu copper peptide research
  2. PubMed, GHK tripeptide skin